Radiosensitivity and oxidative signalling in ataxia telangiectasia: An update

Radiotherapy and Oncology

Volumn 47, Issue 2, 1998, Pages 113-123

  Lavin, Martin F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Ataxia telangiectasia; Oxidative signalling; Radiosensitivity

Indexed keywords

ATAXIA TELANGIECTASIA; CANCER SUSCEPTIBILITY; GENETIC SUSCEPTIBILITY; HUMAN; IONIZING RADIATION; MOLECULAR CLONING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; GENES; HUMANS; OXIDATION-REDUCTION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0031803225     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00027-9     Document Type: Review

References (156)

1. Adams, G.E., Hasan, N.M. and Joiner, M.C. The klaas breur lecture. Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiother. Oncol. 44: 101-109, 1997.
2. Agarwal, M.L., Agarwal, A., Taylor, W.R. and Stark, G.R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92: 8493-8497, 1995.
3. Al-Khodairy, F. and Carr, A.M. DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe. EMBO J. 11: 1343-1350, 1992.
4. Aloni-Grinstein, R., Schwartz, D. and Rotter, V. Accommodation of wild-type p53 protein upon γ-irradiation induces a G2 arrest-dependent immunoglobulin k light chain gene expression. EMBO J. 14: 1392-1401, 1994.
5. Anderson, C.W. and Carter, T.H. The DNA-activated protein-kinase - DNA-PK. In: Current Topics in Microbiology and Immunology Vol. 217, Molecular Analysis of DNA Rearrangements in the Immune System, pp. 91-111. Editors: R. Jessberger and M.R. Lieber. 1996.
6. Arlett, C.F., Harcourt, S.A., Teo, I.A. and Broughton, B.C. The response of ataxia-telangiectasia fibroblasts to the lethal effects of an array of DNA-damaging agents. In: Ataxia-Telangiectasia - A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, pp. 169-176. Editors: B.A. Bridges and D.G. Harnden. Wiley, New York, 1982.
7. Artuso, M., Esteve, A., Bresil, H., Vuillaume, M. and Hall, J. The role of the ataxia-telangiectasia gene in the p53, WAF1/CIP1(p21) GADD45-mediated response to DNA damage produced by ionizing radiation. Oncogene 8: 1427-1435, 1995.
8. Aurias, A.B., Dutrillaux, D.B. and Lejeune, J. High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia-telangiectasia. Mutat. Res. 69: 369-374, 1980.
9. Badie, C., Iliakis, G., Foray, N., et al. Defective repair of DNA double-strand breaks and chromosome damage in fibroblasts from a radiosensitive leukemia patient. Cancer Res. 55: 1232-1234, 1995.
10. Barlow, C., Hirotsune, S., Paylor, R., et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171, 1996.
11. Baskaran, R., Wood, L.D., Whitaker, L.L., et al. Ataxia-telangiectasia mutated gene product activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516-520, 1997.
12. Bates, P.R., Imray, F.P. and Lavin, M.F. Effect of caffeine on γ-ray induced G2 delay in ataxia telangiectasia. Int. J. Radiat. Biol. 47: 713-722, 1985.
13. Beamish, H. and Lavin, M.F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65: 175-184, 1994.
14. Beamish, H., Williams, R., Chen, P. and Lavin, M.F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia post-irradiation. J. Biol. Chem. 271: 20486-20493, 1996.
15. Blocher, D., Sigut, D. and Hannan, M.A. Fibroblasts from ataxia-telangiectasia (A-T) and A-T heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate γ-radiation as assayed by pulsed field gel electrophoresis. Int. J. Radiat. Biol. 60: 791-802, 1991.
16. Boder, E. Ataxia-telangiectasia: an overview. In: Ataxia-Telangiectasia, pp. 1-63. Editors: R.A. Gatti and M. Swift. Alan R. Liss, New York, 1985.
17. Boder, E. and Sedgwick, R.P. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history. Univ. Sth. Calif. Med. Bull. 9: 15-28, 1957.
18. Boder, E. and Sedgwick, R.P. Ataxia-telangiectasia. A review of 101 cases. In: Little Club Clinics in Developmental Medicine No. 8, pp. 110-118. Editor: G. Walsh. Heinemann Medical Books, London, 1963.
19. Bristow, R.G., Benchimol, S. and Hill, R.P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother. Oncol. 40: 197-223, 1996.
20. Brown, K.D., Ziv, Y., Sadanandan, S.N., et al. The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc. Natl. Acad. Sci. USA 94: 1840-1845, 1997.
21. Byrd, P.J., McConville, C.M., Cooper, P., et al. Mutations revealed by sequencing the 5′ half of the gene for ataxia-telangiectasia. Hum. Mol. Genet. 5: 145-149, 1996.
22. Canman, C.E., Wolff, A.C., Chen, C.Y., Fornace, A.J., Jr. and Kastan, M.B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54: 5054-5058, 1994.
23. Carpenter, C.L. and Cantley, L.C. Phosphoinositide kinases. Biochemistry 29: 11147-11156, 1990.
24. Carpenter, C.L., Auger, K.R., Duckworth, B.C., Hou, W.-M., Schaffhausen, B.S. and Cantley, L.C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol. Cell. Biol. 13: 1657-1665, 1993.
25. Chen, G. and Lee, E.Y.-H.P. The product of the ATM gene is a 370-kDa nuclear phosphoprotein. J. Biol. Chem. 271: 33693-33697, 1996.
26. Chen, P.C., Lavin, M.F., Kidson, C. and Moss, D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274: 484-486, 1978.
27. Chessa, L., Petrinelli, P., Antonelli, A., et al. Heterogeneity in ataxia-telangiectasia: classical phenotype associated with intermediate cellular radiosensitivity. Am. J. Med. Genet. 42: 1992.
28. Cimprich, K.A., Shin, T.B., Keith, C.T. and Schreiber, S.L. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc. Natl. Acad. Sci. USA 93: 2850-2855, 1996.
29. Clarke, A.R., Purdie, C.A., Harrison, D.J., et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
30. Coffer, P.J., Burgering, B.M., Peppelenbosch, M.P., Bos, J.L. and Kruijer, W. UV activation of RTK activity. Oncogene 11: 561-569, 1995.
31. Cohen, M.M. and Simpson, S.J. The effect of bleomycin on DNA synthesis in ataxia-telangiectasia lymphoid cells. Environ. Mutagen. 4: 27-36, 1982.
32. Coleman, N.C. Of what use is molecular biology to the practising radiation oncologist? Radiother. Oncol. 46: 1-9, 1997.
33. Coquerelle, T.M. and Weibezahn, K.F. Rejoining of DNA double-strand breaks in human fibroblasts and its impairment in one ataxia-telangiectasia and two Fanconi strains. J. Supro. Structure Cell. Biochem. 17: 369-376, 1981.
34. 241Am α-particles or bleomycin. Int. J. Radiat. Biol. 51: 209-221, 1987.
35. Cornforth, M.W. and Bedford, J.S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 227: 1589-1591, 1985.
36. Cox, R., Hosking, G.P. and Wilson, J. Ataxia-telangiectasia: evaluation of radiosensitivity in cultured skin fibroblasts as a diagnostic test. Arch. Dis. Child. 53: 386-390, 1978.
37. De Wit, J., Jaspers, N.G.J. and Bootsma, D. The rate of DNA synthesis in normal and ataxia-telangiectasia cells after exposure to X-irradiation. Mutat. Res. 80: 221-226, 1981.
38. Devary, Y., Rosette, C., Didonato, J.A. and Karin, M. NF-kB activation by ultraviolet light not dependent on a nuclear signal. Science 261: 1442-1445, 1993.
39. Dhand, R., Hiles, I., Panayotou, G., et al. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13: 522-533, 1994.
40. Dulic, V., Kaufmann, W.K., Wilson, S.J., et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023, 1994.
41. Edwards, M.J. and Taylor, A.M.R. Unusual levels of (ADP-ribose) and DNA synthesis in ataxia telangiectasia cells following γ-ray irradiation. Nature 287: 745-747, 1981.
42. Elson, A., Wang, Y., Daugherty, C.J., et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA 93: 13084-13089, 1996.
43. Feigin, R.D., Vietti, T.J., Wyatt, R.G., Kaufmann, D.G. and Smith, C.H., Jr. Ataxia-telangiectasia with granulocytopenia. J. Pediatr. 77: 431-438, 1970.
44. Foray, N., Arlett, C.F. and Malaise, E.P. Dose-rate effect on induction and repair rate of radiation-induced DNA double-strand breaks in a normal and an ataxia-telangiectasia human fibroblast cell line. Biochimie 77: 900-905, 1995.
45. Foray, N., Priestley, A., Alsbeih, G., et al. Hypersensitivity of ataxia-telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol. 72: 271-283, 1997.
46. Fornace, A.J., Jr. and Little, J.B. Normal repair of DNA single-strand breaks in patients with ataxia-telangiectasia. Biochem. Biophys. Acta 607: 432-437, 1980.
47. Gatti, R.A., Berkel, I., Boder, E., et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336: 577-580, 1988.
48. Gilad, S., Khosravi, R., Shkedy, D., et al. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5: 433-440, 1996.
49. Gilad, S., Bar-Shira, A., Harnik, R., et al. Ataxia-telangiectasia: founder effect among North African Jews. Hum. Mol. Genet. 5: 2033-2038, 1996.
50. Gotoff, S.P., Amirmokri, E. and Liebner, E.J. Ataxia-telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am. J. Dis. Child. 114: 617-625, 1967.
51. Gottlieb, T.M. and Jackson, S.P. Protein kinases and DNA damage. Trends Biochem. Sci. 19: 500-503, 1994.
52. Hari, K.L., Santerre, A., Sekelsky, J.J., McKim, K.S., Boyd, J.B. and Hawley, R.S. The mei-4l gene of Drosophila melanogaster is functionally homologous to the human ataxia telangiectasia gene. Cell 82: 815-821, 1995.
53. Hartley, K.O., Gell, D., Smith, G.C.M., et al. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidyl-inositol 3-kinase and the ataxia telangiectasia gene product. Cell 82: 849-856, 1995.
54. Hartwell, L.M. and Weinert, T.A. Checkpoints: controls that ensure the order of cell cycle events. Science 246: 629-634, 1989.
55. Hecht, F. and Hecht, B.K. Cancer in ataxia-telangiectasia patients. Cancer Genet. Cytogenet. 46: 9-19, 1990.
56. Hedrick, S.M., Cohen, D.I., Neilsen, E.A. and Davis, M.M. Isolation of cDNA clones encoding T cell-specific membrane associated proteins. Nature 308: 149-153, 1984.
57. Hentze, M.W. Iron-sulfur clusters and oxidant stress responses. Trends Biochem. Sci. 21: 282-283, 1996.
58. Hentze, M.W. and Argos, P. Homology between IRE-BP, a regulatory RNA-binding protein, aconitase, and isopropylomatate isomerase. Nucleic Acids Res. 19: 1739-1744, 1991.
59. Hidalgo, E. and Demple, B. Activation of SoxR-dependent transcription in vitro by noncatalytic or NifS-mediated assembly of [2Fe-2S] clusters into Apo-SoxR. J. Biol. Chem. 271: 7269-7272, 1996.
60. Higurashi, M. and Cohen, P.E. In vitro chromosomal radiosensitivity in 'chromosomal breakage syndromes'. Cancer 32: 380-383, 1973.
61. Houldsworth, J. and Lavin, M.F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res. 8: 3709-3720, 1980.
62. Hsieh, C.-I., Arlett, C.F. and Lieber, M.R. V(D)J recombination in ataxia telangiectasia, Bloom's syndrome and a DNA ligase I-associated immunodeficiency disorder. J. Biol. Chem. 68: 20105-20109, 1993.
63. Hunter, T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83: 1-4, 1995.
64. Jackson, S.P. Ataxia-telangiectasia at the crossroads. Curr. Biol. 5: 1210-1212, 1995.
65. + gene of Schizosaccharomyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc. Natl. Acad. Sci. USA 89: 4952-4956, 1992.
66. Jung, M., Kondratyev, A., Lee, S., Dimtchev, A. and Dritschilo, A. ATM gene product phosphorylates IkB. Cancer Res. 57: 24-27, 1997.
67. Jung, M., Zhang, Y., Lee, S. and Dritschilo, A. Correction of radiation sensitivity in ataxia-telangiectasia cells by a truncated IKB-α. Science 268: 1619-1621, 1995.
68. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinase. J. Biol. Chem. 270: 16483-16486, 1995.
69. Karin, M. and Hunter, T. Transcriptional control by protein phosphorylation: signal transmission from cell surface to the nucleus. Curr. Biol. 5: 747-757, 1995.
70. Kastan, M.B., Zhan, O., EL-Deiry, W.S., et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992.
71. Keegan, K.S., Holtzman, D.A., Plug, A.W., et al. The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev. 10: 2423-2437, 1996.
72. Khanna, K.K. and Lavin, M.F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8: 3307-3312, 1993.
73. Khanna, K.K., Beamish, H., Yan, J., et al. Nature of GS/1 cell cycle checkpoint defect in ataxia-telangiectasia. Oncogene 11: 609-618, 1995.
74. Kharbanda, S., Ren, R., Pandey, P., et al. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785-788, 1995.
75. Khoroshilova, N., Beinert, H. and Kiley, P.J. Association of a polynuclear iron-sulfur center with a mutant FNR protein enhances DNA binding. Proc. Natl. Acad. Sci. USA 92: 2499-2503, 1995.
76. Kirchgessner, C.U., Patil, C.K., Evans, J.W., et al. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267: 1178-1182, 1995.
77. Knebel, A., Rahmsdorf, H.J., Ullrich, A. and Herrlich, P. Dephosphorylation of receptor tyrosine kinases as targets of regulation by radiation, oxidants or alkylating agents. EMBO J. 15: 5314-5325, 1996.
78. Lakin, N.D., Weber, P., Stankovic, T., et al. Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13: 2707-2716, 1996.
79. Lange, E., Borreson, A.-L., Chen, X., et al. Localization of an ataxia-telangiectasia gene to a 850 kb interval on chromosome 11q23.1 by linkage analysis of 176 families in an international consortium. Am. J. Hum. Genet. 57: 112-119, 1995.
80. Lavin, M.F. and Davidson, M. Repair of strand breaks in superhelical DNA of ataxia telangiectasia lymphoblastoid cells. J. Cell Sci. 48: 383-391, 1981.
81. Lavin, M.F., Khanna, K.K., Beamish, H., Spring, K., Watters, D. and Shiloh, Y. Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem. Sci. 20: 382-383, 1995.
82. Lavin, M.F. and Shiloh, Y. Ataxia-telangiectasia: a multifacet genetic disorder associated with defective signal transduction. Curr. Opin. Immunol. 8: 459-464, 1996.
83. Lavin, M.F. and Shiloh, Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15: 177-202, 1997.
84. Lazazzera, B., Beinert, H., Lhoroshilova, N., Kennedy, M.C. and Kiley, P.J. DNA binding and dimerization of the Fe-S-containing FNR protein from Escherichia coli are regulated by oxygen. J. Biol. Chem. 271: 2762-2768, 1996.
85. Lee, J.H. and Bernstein, A. p53 mutation increases resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90: 5742-5746, 1993.
86. Lehmann, A.R. and Stevens, S. The response of ataxia-telangiectasia cells to bleomycin. Nucleic Acids Res. 6: 1953-1960, 1979.
87. Lehmann, A.R., James, M.R. and Stevens, S. Miscellaneous observations on DNA repair in ataxia-telangiectasia. In: Ataxia-Telangiectasia - A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, pp. 347-353. Editors: B.A. Bridges and D.G. Harnden. Wiley, New York, 1982.
88. Li, R. and Murray, A.W. Feedback control of mitosis in budding yeast. Cell 66: 519-531, 1991.
89. Liu, V.F. and Weaver, D.T. The ionizing radiation-induced replication protein A phosphorylation response differs between ataxia-telangiectasia and normal human cells. Mol. Cell. Biol. 13: 7222-7231, 1993.
90. Louis-Bar, D. Sur un syndrome progressif comprenant des telengiectasies capillaires cutanees et conjonctivales symetriques, a disposition naevode et de troubles cerebelleux. Confin. Neurol. (Basel) 4: 32-42, 1941.
91. Lowe, S., Schmitt, E., Smith, S., Osborne, B. and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
92. Lu, X. and Lane, D.P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75: 765-778, 1993.
93. Martins, E.A., Robalinho, R.L. and Meneghini, R. Oxidative stress induces activation of a cytosotic protein responsible for the control of iron intake. Arch. Biochem. Biophys. 316: 128-134, 1995.
94. Meyn, M.S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55: 5591-6001, 1995.
95. Mirzayans, R., Famulski, K.S., Enns, L., Fraser, M. and Paterson, M.C. Characterization of the signal transduction pathway mediating γ-ray-induced inhibition of DNA synthesis in human cells: indirect evidence for involvement of calmodulin but not protein kinase C nor p53. Oncogene 8: 1597-1605, 1995.
96. Morgan, J.L., Holcomb, T.M. and Morrissey, R.W. Radiation reaction in ataxia-telangiectasia. Am. J. Dis. Child. 116: 557-558, 1968.
97. Morgan, S.E., Lovly, C., Pandita, T.K., Shiloh, Y. and Kastan, M.S. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17: 2020-2029, 1997.
98. Morris, C., Mohamed, R. and Lavin, M.F. DNA replication and repair in ataxia-telangiectasia cells exposed to bleomycin. Mutat. Res. 112: 67-74, 1983.
99. Murray, A.W. Creative blocks, cell-cycle checkpoints and feedback controls. Nature 359: 599-604, 1992.
100. Nagasawa, H. and Little, J.B. Comparison of kinetics of X-ray-induced cell killing in normal, ataxia-telangiectasia and hereditary retinoblastoma fibroblasts. Mutat. Res. 109: 297-308, 1983.
101. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature 344: 503-508, 1990.
102. Painter, R.B. and Young, B.R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77: 7315-7317, 1980.
103. Pandita, T.K. and Hittleman, W.N. Increased initial levels of chromosome damage and heterogeneous chromosome repair in ataxia-telangiectasia heterozygote cells. Mutat. Res. 310: 1-13, 1994.
104. Pandita, T.K. and Hittleman, W.N. The contribution of DNA and chromosome repair deficiencies to the radiosensitivity of ataxia-telangiectasia. Radiat. Res. 131: 214-223, 1992.
105. Pandita, T.K. and Hittleman, W.N. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130: 94-103, 1992.
106. Paterson, M.C., Smith, B.P., Lohman, P.H., Andrews, A.K. and Fishman, I. Defective excision repair of gamma ray damaged DNA in human (ataxia-telangiectasia) fibroblasts. Nature 260: 444-447, 1976.
107. Paules, R.S., Levedakou, E.N., Wilson, S.J., et al. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res. 8: 1763-1773, 1995.
108. Paulovich, A.G. and Hartwell, L.H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82: 841-847, 1995.
109. Plowman, P.N., Bridges, B.A., Arlett, C.F., Hinney, A. and Kingston, J.E. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. Br. J. Radiol. 63: 624-628, 1990.
110. Rary, J.M., Bender, M.A. and Kelly, T.E. A 14/14 marker chromosome lymphocyte clone in ataxia-telangiectasia. J. Hered. 66: 33-35, 1975.
111. Rouault, T.A., Stout, C.D., Kaptain, S., Harford, J.B. and Klansner, R.D. Structural relationships between an iron-regulated RNA binding protein (IRE-BP) and aconitase: functional implications. Cell 64, 881-883, 1991.
112. Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P. and Rahmsdorf, H.J. Involvement of growth factor receptors in the mammalian UVC response. Cell 78: 963-972, 1994.
113. Savitsky, K., Bar-Shira, A., Gilad, S., et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
114. Savitsky, K., Sfez, S., Tagle, D., et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4: 2025-2032, 1995.
115. 2 induced signal transduction. J. Biol. Chem. 260: 20718-20726, 1994.
116. Scott, D. and Zampetti-Bosseler, F. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts. Int. J. Radiat. Biol. 42: 679-683, 1982.
117. Sedgwick, R.P. and Boder, E. Ataxia-telangiectasia (208900; 208910; 208920). In: Hereditary Neuropathies and Spinocerebellar Atrophies, pp. 347-423. Editor: J.M.B. Vianney De Jong. Elsevier, Amsterdam, 1991.
118. Shafman, T., Khanna, K.K., Kedar, P., et al. Role of the ATM protein in stress response to DNA damage: evidence for interaction with c-Abl. Nature 387: 520-523, 1997.
119. Shafman, T.D., Saleem, A., Kyriakis, J., Weichselbaum, R., Kharbanda, S. and Kufe, D.W. Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res. 55: 3242-3245, 1995.
120. Shiloh, Y., Tabor, E. and Becker, Y. Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis 4: 1317-1322, 1983.
121. Shiloh, Y., Tabor, E. and Becker, Y. Colony-forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors. Exp. Cell. Res. 140: 191-199, 1982.
122. Sidoo-Atwal, C., Haas, A.L. and Rosin, M.P. Elevation of interferon β-inducible proteins in ataxia-telangiectasia cells. Cancer Res. 56: 443-447, 1996.
123. Sies, H. Oxidative Stress. Oxidants and Antioxidants, p. 650. Academic Press, London, 1991.
124. Sim, G.K., Yague, J., Nelson, J., et al. Primary structure of human T cell receptor alpha chain. Nature 312: 771-775, 1984.
125. Singh, S.P. and Lavin, M.F. DNA-binding protein activated by γ-radiation in human cells. Mol. Cell. Biol. 10: 5279-5285, 1990.
126. Slichenmyer, W.J., Nelson, W.G., Slebos, R.J. and Kastan, M.B. Loss of a p53 associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53: 4164-4168, 1993.
127. Spector, B.D., Filipovich, A.H., Perry, G.S., III and Kersey, J.H. Epidemiology of cancer in ataxia-telangiectasia. In: Ataxia-Telangiectasia - A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, pp. 103-138. Editors: B.A. Bridges and D.G. Harnden. Wiley, New York, 1982.
128. Syllaba, K. and Henner, K. Contribution a l'independance de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1: 541-562, 1976.
129. Taccioli, G.E., Rathbun, G., Oltz, G., Stamato, T., Jeggo, P. and Alt, F.W. Impairment of V(D)J recombination in double-strand break repair mutants. Science 260: 207-210, 1993.
130. Taylor, A.M., Harnden, D.G., Arlett, C.F., et al. Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 4: 427-429, 1975.
131. Taylor, Y.C., Duncan, P.G., Zhang, X. and Wright, W.D. Differences in the DNA supercoiling response of irradiated cell lines from ataxia-telangiectasia versus unaffected individuals. Int. J. Radiat. Biol. 59: 359-371, 1991.
132. Taylor, A.M.R., Flude, E., Laher, B., et al. Variant forms of ataxia-telangiectasia. J. Med. Genet. 24: 669-677, 1987.
133. Teale, B., Khanna, K.K., Singh, S.P. and Lavin, M.F. Radiation-activated DNA-binding protein constitutively present in ataxia-telangiectasia nuclei. J. Biol. Chem. 268: 22450-22455, 1993.
134. Telatar, M., Wang, Z., Udar, W., et al. Ataxia-telangiectasia: mutations in cDNA detected by protein truncation screening. Am. J. Hum. Genet. 59: 40-44, 1996.
135. Thompson, L.H. and Jeggo, P.A. Nomenclature of human genes involved in ionizing radiation sensitivity. Mutat. Res. 337: 131-134, 1995.
136. Urhammer, N., Lange, E., Porras, O., et al. Sublocalization of an ataxia-telangiectasia gene distal to D11S384 by ancestral haplotyping in Costa Rican families. Am. J. Hum. Genet. 57: 103-111, 1995.
137. Uziel, T., Savitsky, K., Platzer, M., et al. Genomic organization of the ATM gene. Genomics 33: 317-320, 1996.
138. 60Co-γ-radiation, 4-nitroquinoline-1-oxide or bleomycin. In: Ataxia-Telangiectasia - A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency, pp. 291-303. Editors: B.A. Bridges and D.G. Harnden. Wiley, New York, 1982.
139. Vanagaite, L., James, M.R., Rotman, G., et al. A high-density microsatellite map of the ataxia-telangiectasia locus. Hum. Genet. 95: 451-455, 1995.
140. Verheij, et al., The role of the stress activated protein kinase (SAPK/JNK) signalling pathway in radiation-induced apoptosis. Radiother. Oncol. 1998, in press.
141. Vincent, R.A., Jr., Sheriden, R.B., 3rd. and Huang, P.C. DNA strained breakage repair in ataxia-telangiectasia fibroblast-like cells. Mutat. Res. 33: 357-366, 1975.
142. Vuillaume, M. Reduced oxygen species, mutation, induction and cancer initiation. Mutat. Res. 186: 43-72, 1987.
143. Watters, D., Khanna, K.K., Beamish, H., et al. Cellular localisation of the ataxia-telangiectasia (ATM) gene proteins and discrimination between mutated and normal forms. Oncogene 14: 1911-1921, 1997.
144. Weinert, T.A. and Hartwell, L.H. Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts post translationally in cell cycle arrest after DNA damage. Mol. Cell. Biol. 10: 6554-6564, 1990.
145. Weinert, T.A., Kiser, G.L. and Hartwell, L.H. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 8: 652-665, 1994.
146. Xiong, Y., Zhang, H. and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7: 1572-1583, 1993.
147. Xu, Y. and Baltimore, D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10: 2401-2410, 1996.
148. Xu, Y., Brainerd, E.E., Bronson, R.T., Meyn, M.S. and Baltimore, D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10: 2411-2422, 1996.
149. Yarnold, J. Molecular aspects of cellular responses to radiotherapy. Radiother. Oncol. 44: 1-7, 1997.
150. Yuan, A.M., Huang, Y., Whang, Y., et al. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382: 272-274, 1996.
151. Zakian, V.A. ATM-related genes: what do they tell us about functions of the human gene? Cell 82: 685-687, 1995.
152. Zdzienicka, M.Z. Mammalian mutants defective in the response to ionizing radiation-induced DNA damage. Mutat. Res. 336: 203-213, 1995.
153. Zheng, X.-F., Fiorentino, D., Chen, J., Crabtree, G.R. and Schreiber, S.L. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82: 121-130, 1995.
154. Zhang, N., Chen, P., Khanna, K.K., et al. Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Proc. Natl. Acad. Sci. USA 94: 8021-8026, 1997.
155. Ziv, Y., Amiel, A., Jaspers, N.G., Berkel, A.I. and Shiloh, Y. Ataxia-telangiectasia: a variant with altered in vitro phenotype of fibroblast cells. Mutat. Res. 210: 211-219, 1989.
156. Ziv, Y., Bar-Shira, A., Pecker, I., et al. Recombinant ATM protein complements the A-T phenotype. Oncogene 15: 159-167.